Clinical Trial Update: Plinabulin iv Solution in Prevention of TAC Induced Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Plinabulin intravenous solution in preventing TAC-induced neutropenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• Plinabulin (plinabulin)

Snippet

Sponsor: BeyondSpring Pharmaceuticals Inc. | Conditions: Chemotherapy-induced Neutropenia | Phase 2 | Status: COMPLETED